Opportunity Information: Apply for CDC RFA PS15 1511
Apply for CDC RFA PS15 1511
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evaluation of STD Programs Deploying Disease Intervention Specialist (DIS) to Improve Human Immunodeficiency Virus (HIV) Outcomes" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.977 Preventive Health ServicesSexually Transmitted Diseases Control Grants.
- This funding opportunity was created on Jul 15, 2015 and posted on Jun 26, 2015.
- Applicants must submit their applications by Aug 25, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) County governments State governments City or township governments Special district governments.
- Applicants are limited to the 59 state and local health departments funded for the ldquoImproving STDs through Assessment, Assurance, Policy, and Prevention Servicesrdquo (STD AAPPS) FOA. These include Government Organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This Centers for Disease Control and Prevention (CDC) funding opportunity (CDC RFA PS15-1511) supports a multi-site evaluation of how state and local sexually transmitted disease (STD) programs use Disease Intervention Specialists (DIS) to improve key human immunodeficiency virus (HIV) outcomes. The core idea is to study, in real-world health department settings, whether and how expanding or refocusing DIS activities can help meet National HIV/AIDS Strategy goals, especially finding previously undiagnosed HIV infections, linking people to HIV medical care, re-engaging people who have fallen out of care, and connecting HIV-negative people at elevated risk to prevention services such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Rather than funding general service delivery alone, the FOA emphasizes structured evaluation so that programs can document what works, what it costs, and what implementation lessons can be applied elsewhere.
The intervention being evaluated is the strategic deployment of the DIS workforce. DIS are specialized public health outreach professionals traditionally funded and housed within STD programs, with longstanding responsibility for partner services and related fieldwork. Their work often involves confidential, time-intensive efforts to locate patients and partners, conduct counseling, elicit sexual and other relevant contacts, and connect people to testing and treatment. DIS commonly operate in community settings and may meet clients in homes, on the street, or wherever people can safely and discreetly be found. They also rely on public health data systems and other resources to find individuals and facilitate connections to care. Because DIS routinely interact with people affected by STDs and their networks, they tend to have strong knowledge of local communities, clinical providers, and community-based organizations, positioning them as practical connectors between public health programs and frontline services.
The FOA is built on the public health reality that STD diagnoses, particularly among certain populations such as men who have sex with men, can be a strong marker of increased HIV risk. For decades, clinical and partner services guidance has emphasized HIV testing for STD patients and their partners, alongside risk-reduction counseling and referrals to prevention and care. In more recent years, the potential value of DIS involvement in HIV outcomes has increased due to several converging developments: the release and prioritization of the US National HIV/AIDS Strategy, the introduction of formal PrEP guidelines, improvements in health department and clinic information technology systems, closer integration of HIV and STD programs within agencies, and growing evidence of STD/HIV co-infection (including notable overlap with syphilis). Many jurisdictions have begun exploring enhanced models in which DIS spend more time on HIV case finding, PrEP linkage, linkage to HIV care, and re-engagement of people who are not currently in care. The FOA notes that while these approaches appear promising, there is limited documentation about best implementation practices and about costs and benefits for both clients and programs, which is why a formal evaluation effort is being funded.
Funding is provided through a cooperative agreement, meaning the CDC anticipates substantial involvement with awardees in carrying out the evaluation work. The opportunity is categorized as discretionary funding in the health area, with an estimated total funding amount of $4,000,000 and an expected 4 awards. The award ceiling is $750,000, with no stated award floor, and there is no cost sharing or matching requirement. Eligible applicants are limited to the 59 state and local health departments funded under the STD AAPPS initiative ("Improving STDs through Assessment, Assurance, Policy, and Prevention Services"), which restricts eligibility to a defined set of government organizations (including state, county, city/township, and special district governments that are part of that funded cohort). The original posting date was June 26, 2015, with an application due date of August 25, 2015, and an archive date of September 24, 2015.
In practical terms, awardees under this FOA are expected to conduct both process and outcome evaluations of their local DIS deployment strategies focused on HIV outcomes. Process evaluation generally captures how the model is implemented (workflows, staffing, training, partnerships, data use, barriers, facilitators, and fidelity to the intended approach), while outcome evaluation examines whether the model improves measurable HIV-related endpoints such as new HIV diagnoses, successful linkage to care, re-linkage for people previously diagnosed, and uptake or referral completion for prevention services like PrEP. The broader goal of the multi-site evaluation is to produce actionable, field-tested lessons that other health departments can use if they are considering similar shifts in how DIS time and expertise are applied to strengthen HIV prevention and care outcomes. For additional information, the listed CDC contact for the announcement is Chris Lupoi (cjl0@cdc.gov).
Frequently Asked Questions (FAQs)
What is CDC RFA PS15-1511 about?
CDC RFA PS15-1511 is a Centers for Disease Control and Prevention (CDC) funding opportunity that supports a multi-site evaluation of how state and local sexually transmitted disease (STD) programs use Disease Intervention Specialists (DIS) to improve key human immunodeficiency virus (HIV) outcomes in real-world health department settings.
What is the main purpose of this funding opportunity?
The purpose is to evaluate whether and how expanding or refocusing DIS activities can help meet National HIV/AIDS Strategy goals. The emphasis is on structured evaluation so programs can document what works, what it costs, and what implementation lessons can be applied elsewhere, rather than funding general service delivery alone.
What kinds of HIV outcomes is the evaluation focused on?
The evaluation focuses on outcomes aligned with National HIV/AIDS Strategy goals, including finding previously undiagnosed HIV infections, linking people to HIV medical care, re-engaging people who have fallen out of care, and connecting HIV-negative people at elevated risk to prevention services such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
What intervention is being evaluated under this FOA?
The intervention is the strategic deployment of the DIS workforce. This includes studying models where DIS time and activities are expanded or refocused to strengthen HIV case finding, linkage to care, re-engagement in care, and connections to HIV prevention services.
Who are Disease Intervention Specialists (DIS)?
DIS are specialized public health outreach professionals traditionally funded and housed within STD programs. They have longstanding responsibility for partner services and related fieldwork, often involving confidential and time-intensive efforts to locate patients and partners, conduct counseling, elicit contacts, and connect people to testing and treatment.
Where do DIS typically work and what resources do they use?
DIS commonly operate in community settings and may meet clients in homes, on the street, or wherever people can safely and discreetly be found. They also use public health data systems and other resources to locate individuals and facilitate connections to care.
Why is the DIS workforce considered important for improving HIV outcomes?
Because DIS routinely interact with people affected by STDs and their networks, they often have strong knowledge of local communities, clinical providers, and community-based organizations. This positions them as practical connectors between public health programs and frontline testing, prevention, and treatment services.
Why does this FOA link STD work to HIV outcomes?
The FOA is based on the public health reality that STD diagnoses can be a strong marker of increased HIV risk, particularly among certain populations such as men who have sex with men. For decades, guidance has emphasized HIV testing for STD patients and their partners alongside counseling and referrals to prevention and care.
What recent developments made DIS involvement in HIV outcomes more relevant?
The FOA cites several converging developments: prioritization of the US National HIV/AIDS Strategy, the introduction of formal PrEP guidelines, improvements in health department and clinic information technology systems, closer integration of HIV and STD programs within agencies, and growing evidence of STD/HIV co-infection (including overlap with syphilis).
What problem is this funding opportunity trying to address?
Many jurisdictions are exploring enhanced DIS models that appear promising, but there is limited documentation about best implementation practices and about costs and benefits for both clients and programs. This FOA funds a formal evaluation effort to generate that evidence.
Is this grant funding meant for direct service delivery?
The FOA emphasizes structured evaluation rather than funding general service delivery alone. Awardees are expected to evaluate their DIS deployment strategies focused on HIV outcomes and document effectiveness, costs, and implementation lessons.
What type of funding mechanism is used?
Funding is provided through a cooperative agreement, which means CDC anticipates substantial involvement with awardees in carrying out the evaluation work.
What does CDC involvement mean in a cooperative agreement?
Based on the FOA description, CDC expects substantial involvement with awardees as they conduct the multi-site evaluation and carry out evaluation-related activities.
How much funding is available in total?
The estimated total funding amount is $4,000,000.
How many awards does CDC expect to make?
The FOA states an expected 4 awards.
What is the maximum award amount per recipient?
The award ceiling is $750,000.
Is there a minimum award amount?
No award floor is stated in the provided information.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
Who is eligible to apply?
Eligible applicants are limited to the 59 state and local health departments funded under the STD AAPPS initiative ("Improving STDs through Assessment, Assurance, Policy, and Prevention Services"). This restricts eligibility to a defined set of government organizations in that funded cohort, including state, county, city/township, and special district governments.
Can organizations outside the STD AAPPS-funded cohort apply?
No. Eligibility is restricted to the 59 state and local health departments funded under the STD AAPPS initiative, as described in the opportunity information provided.
What is the focus of the evaluation awardees are expected to conduct?
Awardees are expected to conduct both process and outcome evaluations of local DIS deployment strategies focused on HIV outcomes.
What is a process evaluation in this FOA?
Process evaluation generally captures how the model is implemented, including workflows, staffing, training, partnerships, data use, barriers, facilitators, and fidelity to the intended approach.
What is an outcome evaluation in this FOA?
Outcome evaluation examines whether the model improves measurable HIV-related endpoints such as new HIV diagnoses, successful linkage to care, re-linkage for people previously diagnosed, and uptake or referral completion for prevention services like PrEP.
What HIV prevention services are specifically mentioned?
The opportunity specifically mentions connecting HIV-negative people at elevated risk to prevention services such as PrEP and PEP, and it also references evaluation of uptake or referral completion for services like PrEP.
What is meant by "multi-site evaluation" in this context?
"Multi-site evaluation" means the evaluation will be conducted across multiple state and local health department settings, with the broader goal of producing lessons and findings that can be informative beyond a single jurisdiction.
What is the broader goal of funding multiple sites?
The broader goal is to produce actionable, field-tested lessons that other health departments can use if they are considering similar shifts in how DIS time and expertise are applied to strengthen HIV prevention and care outcomes.
What is the funding opportunity number and name?
The funding opportunity is identified as CDC RFA PS15-1511.
What agency is offering this opportunity?
The offering agency is the Centers for Disease Control and Prevention (CDC).
How is this opportunity categorized?
It is categorized as discretionary funding in the health area.
When was the opportunity posted and when was it due?
The original posting date was June 26, 2015, and the application due date was August 25, 2015.
When was the opportunity archived?
The archive date listed is September 24, 2015.
Who is the CDC contact for more information?
The listed CDC contact is Chris Lupoi (cjl0@cdc.gov).
What kinds of implementation details are expected to be captured during the evaluation?
The FOA highlights implementation details such as workflows, staffing, training, partnerships, data use, barriers and facilitators, and fidelity to the intended DIS deployment approach.
What kinds of measurable endpoints are mentioned for evaluating success?
Examples mentioned include new HIV diagnoses, successful linkage to HIV medical care, re-linkage (re-engagement) for people previously diagnosed and out of care, and uptake or referral completion for prevention services such as PrEP.
Browse more opportunities from the same category: Health
Next opportunity: BLM OR WA SUSTAINABLE RANGELANDS ROUNDTABLE (for WASHINGTON DC)
Previous opportunity: Women in University Administration Professional Exchange
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 1511
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 1511) also looked into and applied for these:
| Funding Opportunity |
|---|
| To Strengthen Collaboration Between CDC the National TB Controllers Association (NTCA) TB Nurse Coalition Supplement Project Apply for CDC RFA PS12 12050401SUPP15 Funding Number: CDC RFA PS12 12050401SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Limited Competition Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) Apply for RFA HL 16 020 Funding Number: RFA HL 16 020 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Service Delivery and Support for Orphans and Vulnerable Children (SDS OVC MZ) Apply for RFA 656 15 000006 Funding Number: RFA 656 15 000006 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $72,000,000 |
| Service Area Competition Apply for HRSA 16 004 Funding Number: HRSA 16 004 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 16 002 Funding Number: RFA NS 16 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Networks to Develop Priority Areas of Behavioral and Social Research (R24) Apply for RFA AG 16 008 Funding Number: RFA AG 16 008 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| Tuberculosis Elimination and Laboratory Cooperative Agreement Apply for CDC RFA PS15 150102CONT16 Funding Number: CDC RFA PS15 150102CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands Apply for CDC RFA PS13 130104CONT16 Funding Number: CDC RFA PS13 130104CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Biomedical Advanced Research and Development Authority Special Projects Apply for EP IDS 15 002 Funding Number: EP IDS 15 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $200,000 |
| International Research Scientist Development Award (IRSDA) (K01) Apply for PAR 15 291 Funding Number: PAR 15 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research to Address Health Disparities (Admin Supp) Apply for PA 15 293 Funding Number: PA 15 293 Agency: National Institutes of Health Category: Health Funding Amount: $45,000 |
| Tuberculosis Regional Training and Medical Consultation Centers Apply for CDC RFA PS13 130404CONT16 Funding Number: CDC RFA PS13 130404CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Project (Collaborative U01) Apply for RFA AA 16 001 Funding Number: RFA AA 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Resource Core (U24) Apply for RFA AA 16 003 Funding Number: RFA AA 16 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Administrative Resource Core (U24) Apply for RFA AA 16 002 Funding Number: RFA AA 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Smallpox Research Oversight ActivitiesWHO Advisory Committee on Variola Virus Research Apply for EP IDS 15 003 Funding Number: EP IDS 15 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $315,000 |
| Claude D. Pepper Older Americans Independence Centers (P30) Apply for RFA AG 16 011 Funding Number: RFA AG 16 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 15 295 Funding Number: PA 15 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research Clinical Decision Support Learning Network (U18) Apply for RFA HS 15 003 Funding Number: RFA HS 15 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Healthy Parks, Healthy People Apply for P15AS00202 Funding Number: P15AS00202 Agency: National Park Service Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 1511", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.